Annaliesa Anderson | SVP and Head, Vaccine R&D
Pfizer

Annaliesa Anderson, SVP and Head, Vaccine R&D, Pfizer

Appearances:



Day 1 - Tuesday 2nd April @ 15:40

Keynote panel: Gaps in Adult Immunization – the next frontier: What is our strategy for better disease prevention and control?

  • As the adult vaccination choices get more crowded, what are our implementation strategies and key challenges?
  • How do we navigate current ACIP recommendations for best vaccine uptake of RSV?
  • How will that impact other new adult vaccines reaching the market?
  • Co-administrating vaccines vs combination vaccines – how do we evaluate these?
last published: 27/Mar/24 22:15 GMT

back to speakers